Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 44Pancreatic Neoplasms 39Rectal Neoplasms 20Colonic Neoplasms 19Stomach Neoplasms 18Neoplasm Metastasis 16Esophageal Neoplasms 13Cholangiocarcinoma 13Barrett Esophagus 11Carcinoma, Hepatocellular 10Ovarian Neoplasms 9Breast Neoplasms 9Adenocarcinoma Of Esophagus 9Melanoma 8Anus Neoplasms 8Neoplasms 7Sarcoma 6Lung Neoplasms 6Liver Neoplasms 6Glioma 6Gastroesophageal Reflux 6Gallbladder Neoplasms 6Uterine Cervical Neoplasms 5Lymphoma, Non-Hodgkin 5Hepatoblastoma 5Esophageal Squamous Cell Carcinoma 5Endometrial Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Adenomatous Polyposis Coli 5Wilms Tumor 4

Interventions

pembrolizumab 5Nivolumab 5Ipilimumab 4avelumab 3Neoadjuvant Therapy 3toripalimab 2durvalumab 2atezolizumab 2Specimen Handling 2Immune Checkpoint Inhibitors 2Celecoxib 2tislelizumab 1spartalizumab 1sintilimab 1regorafenib 1fludarabine phosphate 1fludarabine 1danvatirsen 1camrelizumab 1Taxes 1Surgical Procedures, Operative 1Radiation Dose Hypofractionation 1Paclitaxel 1Oxaliplatin 1Magnetic Resonance Spectroscopy 1Leucovorin 1Irinotecan 1Interleukin-2 1Immunoglobulin G 1IMM-101 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Turcot syndrome × Biopsy × Gastrointestinal × Clear all
NCT04906382 2025-02-13

Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer

Ohio State University Comprehensive Cancer Center

Phase EARLY_PHASE1 Terminated
2 enrolled
GastrointestinalGynecologic

Turcot syndrome, Colorectal Neoplasms, Hereditary Nonpolyposis, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡